Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
Ophthalmology. Retina - 6(2022), 1 vom: 01. Jan., Seite 91-93 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Deaner, Jordan D [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 11.03.2022 Date Revised 11.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.oret.2021.08.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329969420 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329969420 | ||
| 003 | DE-627 | ||
| 005 | 20231225210258.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.oret.2021.08.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1099.xml |
| 035 | |a (DE-627)NLM329969420 | ||
| 035 | |a (NLM)34454124 | ||
| 035 | |a (PII)S2468-6530(21)00258-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Deaner, Jordan D |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2022 | ||
| 500 | |a Date Revised 11.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a AIR | |
| 650 | 4 | |a Anti–IL-6 | |
| 650 | 4 | |a Autoimmune retinopathy | |
| 650 | 4 | |a Biologic | |
| 650 | 4 | |a CAR | |
| 650 | 4 | |a Cancer-associated retinopathy | |
| 650 | 4 | |a IL-6 | |
| 650 | 4 | |a Interleukin 6 | |
| 650 | 4 | |a MAR | |
| 650 | 4 | |a Melanoma associated retinopathy | |
| 650 | 4 | |a Nonparaneoplastic | |
| 650 | 4 | |a Posterior uveitis | |
| 650 | 4 | |a Sarilumab | |
| 650 | 4 | |a Tocilizumab | |
| 650 | 4 | |a Uveitis | |
| 650 | 4 | |a npAIR | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Interleukin-6 |2 NLM | |
| 650 | 7 | |a tocilizumab |2 NLM | |
| 650 | 7 | |a I031V2H011 |2 NLM | |
| 650 | 7 | |a sarilumab |2 NLM | |
| 650 | 7 | |a NU90V55F8I |2 NLM | |
| 700 | 1 | |a Jaffe, Glenn J |e verfasserin |4 aut | |
| 700 | 1 | |a Keenan, Robert T |e verfasserin |4 aut | |
| 700 | 1 | |a Carnago, Lisa |e verfasserin |4 aut | |
| 700 | 1 | |a Grewal, Dilraj S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ophthalmology. Retina |d 2017 |g 6(2022), 1 vom: 01. Jan., Seite 91-93 |w (DE-627)NLM271223650 |x 2468-6530 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2022 |g number:1 |g day:01 |g month:01 |g pages:91-93 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.oret.2021.08.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2022 |e 1 |b 01 |c 01 |h 91-93 | ||